HIV PREVENTION
2025
Getting on track to end AIDS
as a public health threat by 2030
ROAD MAP
Fewer than
370,000
annual new HIV
infections by 2025
1.5 million
new HIV
infections
in 2020
CONTENTS
About the HIV Prevention 2025 Road Map 02
Getting HIV prevention on track to end AIDS 08
Ten-point plan for country-level actions to reach the 2025
targets and get on track to end AIDS by 2030
12
Staying focused on the ve prevention pillars 20
An accountability framework for HIV prevention 26
Annexes 30
Annex 1 Commitments towards reducing new HIV infections
to fewer than 370 000 by 2025 30
Annex 2 Detailed HIV prevention targets in the Global AIDS Strategy
2021–2026 32
Annex 3 Members of the Global HIV Prevention Coalition 37
Annex 4 Successful HIV prevention supports achievement of the
Sustainable Development Goals 38
Annex 5 Summary of achievements and lessons from implementation
of the 2020 HIV Prevention Road Map 39
Annex 6 The Global HIV Prevention Coalition in the context of other
initiatives 41
Annex 7 Reference list and further reading 42
ABOUT THE HIV PREVENTION 2025
ROAD MAP
The Global HIV Prevention Coalition works to accelerate progress on HIV prevention with
a particular focus on countries where numbers of new HIV infections are highest or where
they are rising. Created in 2017, the coalition seeks to build commitment, momentum,
investment and accountability across governments, civil society, donors and the private
sector to implement large-scale, high-coverage, equitable and high-quality prevention
programmes that can end the AIDS epidemic as a public health threat by 2030.
The HIV Prevention 2025 Road Map offers guidance to all stakeholders who are seeking
to reduce new HIV infections. All countries––whether or not they participated in the
Global HIV Prevention Coalition in the past––have to intensify their HIV prevention efforts
to end the AIDS epidemic. The 28 focus countries of the Coalition together accounted
for almost three quarters of annual new HIV infections globally in 2020. Exceptional
international and national efforts are needed in those countries.
1
Several countries, regions and cities are experiencing rising numbers of new HIV
infections and those with ongoing, high burdens of new HIV infections are especially
encouraged to implement the new Road Map and report on progress through the Global
AIDS Monitoring systems.
2-42,3,4
This new Road Map charts a way forward for country-level actions (Figure 1) to achieve
an ambitious set of HIV prevention targets by 2025. Those targets emerged from the
2021 Political Declaration on HIV and AIDS, which the United Nations General Assembly
adopted in June 2021 (Figure 2 and Table 1) and they are underpinned by the Global
AIDS Strategy (2021–2026). The Strategy sets out the principles, approaches, priority
action areas and programmatic targets for the global HIV response.
5
1 Angola, Botswana, Brazil, Cameroon, China, Côte d’Ivoire, Democratic Republic of the Congo, Eswatini, Ethiopia, Ghana, India, Indonesia,
Islamic Republic of Iran, Kenya, Lesotho, Malawi, Mexico, Mozambique, Myanmar, Namibia, Nigeria, Pakistan, South Africa, United Republic
of Tanzania, Uganda, Ukraine, Zambia and Zimbabwe.
2 Decisions of the 47th session of the UNAIDS Programme Coordinating Board, Geneva, Switzerland, 15–18 December 2020
(https://www.unaids.org/sites/default/les/media_asset/Decisions_(PCB47)_Final_EN_rev1.pdf).
3 2021 Global AIDS Monitoring. Geneva: UNAIDS; 2021
(https://www.unaids.org/sites/default/les/media_asset/GAM_reporting_process_en.pdf).
4 2021 Political Declaration on HIV and AIDS. A/RES/75/284. New York: United Nations General Assembly; 2021.
5 Global AIDS Strategy 2021–2026: End inequalities, end AIDS. Geneva: UNAIDS; 2021
(https://www.unaids.org/sites/default/les/media_asset/global-AIDS-strategy-2021-2026_en.pdf).
Member States, in the
2021 Political Declaration
on HIV and AIDS,
agreed to prioritize HIV
prevention and reduce
new HIV infections to
fewer than 370 000 per
year by 2025.
2
Adopt a precision prevention
approach focused on key and
priority populations including
differentiated national
2025 prevention targets
Strengthen and expand
community-led HIV
prevention services and set
up social contracting
mechanisms
Define country investment
needs for an adequately
scaled HIV prevention
response and ensure
sustainable financing
Conduct a data-driven
assessment of HIV
prevention programme
needs and barriers
Remove social and
legal barriers to HIV
prevention services for
key and priority
populations
Promote integration of
HIV prevention into
essential related services
to improve HIV outcomes
Establish real-time
prevention programme
monitoring systems with
regular reporting
Strengthen accountability
of all stakeholders for
progress in HIV prevention
Institute mechanisms for rapid
introduction of new HIV
prevention technologies and
programme innovations
Reinforce HIV prevention
leadership entities for
multisectoral collaboration,
oversight, and management of
prevention responses and set up
social contracting mechanisms
2
10
4
3
7
5
9
8
9
1
FIGURE 1.
The HIV Prevention 2025 Road Map: Ten-point Action Plan
3
This Road Map builds on the previous HIV Prevention 2020 Road Map
6
and responds
to the need for stronger action against the inequalities that hold back progress. It takes
account of an evolving context that is marked by persistent inequalities and overlapping
pandemics, economic challenges, shrinking space for civil society activities, and an
erosion of human rights.
It reects an intensied focus on reaching key populations everywhere and adolescent girls
and young women and their male partners in sub-Saharan Africa, addressing inequalities
that fuel new HIV infections, and strengthening the roles of communities in HIV prevention.
The Road Map guides the use of scarce resources in ways that can achieve maximum
impact and it emphasizes the need to prepare for wider availability and use of innovative
HIV prevention tools (such as long-acting formulations for pre-exposure prophylaxis (PrEP)
methods) and approaches (such as telemedicine and other virtual services).
Figure 2 summarizes overarching prevention targets. Detailed programmatic outcome
targets disaggregated by population and level of risk are summarized in Annex 2.
FIGURE 2.
The 2025 high-level HIV prevention targets and commitments
People-cent red precision
prevention responses
The 2025 Road Map focuses on scaling up primary prevention of HIV infections and on
introducing policy, legal and societal enablers that can prevent people from acquiring HIV
infection. It also highlights the considerable complementarity and interaction between
primary HIV prevention, testing, treatment and the prevention of vertical transmission of HIV.
6 HIV Prevention 2020 Road Map. Geneva: Global HIV Prevention Coalition; 2020 (https://hivpreventioncoalition.unaids.org/road-map/).
The commitments are anchored in the 2025 Global AIDS Strategy
targets, which include the: 95–95–95 targets for access to HIV
services; the 10–10–10 targets for removing social and legal
impediments to accessing or using HIV services; and the use of
integrated approaches to link at least 90% of people who are at
heightened risk of HIV infection to the services they need for their
overall health and well-being.
4
TABLE 1.
The 2025 targets and commitments:
What is new in the 2021 Political Declaration on HIV and AIDS
Ending inequalities: Take urgent and
transformative action to end the social,
economic, racial and gender inequalities that
perpetuate the HIV pandemic.
Equitable outcomes and granular targets:
Achieve HIV combination prevention,
testing and treatment targets across
relevant demographics, populations and
geographical settings.
Prioritized combination HIV prevention:
Prioritize comprehensive packages of HIV
prevention services and ensure they are
available and used by 95% of people at risk
of HIV infection.
Key populations: Act on the recognition
that key populations—including gay men
and other men who have sex with men,
people who inject drugs, sex workers,
transgender people, and people in prisons
and other closed settings—are at high risk
of HIV infection.
New HIV cascade: Reach the new 95–95–95
testing, treatment and viral suppression
targets across all demographics, populations
and geographical settings.
Undetectable = Untransmittable (U = U):
Recognize that viral suppression through
antiretroviral therapy is a powerful
component of combination HIV prevention
(since people living with HIV who have
undetectable viral loads cannot transmit the
infection to others).
Elimination of new HIV infections in
children: Ensure that 95% of pregnant
and breastfeeding women have access
to combination HIV prevention, antenatal
testing and retesting; 95% of women living
with HIV achieve and sustain viral suppression
before delivery and during breastfeeding;
and 95% of HIV-exposed children are tested
within two months of birth and, if HIV-
positive, receive optimized treatment.
Fully fund the HIV response: Invest
US$29billion annually in low- and
middle-income countries, including at least
US$3.1billion for societal enablers.
10–10–10 targets for societal enablers:
Reduce to less than 10% the number of women,
girls and people living with, at risk of and affected
by HIV who experience gender-based inequalities
and sexual and gender-based violence.
Ensure that less than 10% of countries have
restrictive legal and policy environments that lead
to the denial or limitation of access to HIV services.
Ensure that less than 10% of people living with,
at risk of and affected by HIV experience stigma
and discrimination.
Sexual and reproductive health: Ensure that
95% of women and girls of reproductive age
have their HIV and sexual and reproductive
health care service needs met.
Access to affordable medicines, diagnostics,
vaccines and health technologies: Ensure the
global accessibility, availability and affordability
of safe, effective and quality assured medicines
and other health technologies for preventing,
diagnosing and treating HIV infection and its
coinfections and comorbidities.
Service integration: Invest in health and
social protection systems to provide 90% of
people living with, at risk of and affected by
HIV with people-centred and context specic
integrated services.
Community leadership, service delivery
and monitoring: Increase the proportion of
community-led HIV services to achieve 30–
60–80 targets
7
and ensure relevant networks
and organizations are sustainably nanced,
participate in decision-making and can
generate data through community monitoring
and research.
GIPA: Uphold the Greater Involvement of
People Living with or Affected by HIV principle.
Source: UNAIDS, Global AIDS Update 2021
8
7
The term community-led refers to leadership by and for people living with and affected by HIV, including and especially key populations,
women and young people. The 30–60–80 targets are dened as follows in the Global AIDS Strategy: 30% of testing and treatment services
to be delivered by community-led organizations; 60% of the programmes to support the achievement of societal enablers to be delivered
by community-led organizations; 80% of service delivery for HIV prevention programmes for key populations and women to be delivered by
community, key population and women-led organizations.
8 Confronting inequalities: Lessons for pandemic responses from 40 years of AIDS. Global AIDS Update 2021. Geneva: UNAIDS; 2021
(https://www.unaids.org/sites/default/les/media_asset/2021-global-aids-update_en.pdf).
5
The “Hands up for #HIVprevention” campaign in 2016 in Tajikistan united more than 500 people,
including Government ofcials, health professionals, celebrities and young people. Credit: UNAIDS
The new Road Map draws on lessons emerging from implementation of the 2020 Road
Map (see Annex 5). Specically, it builds on the ndings of regular prevention programme
progress reports
9-12
and on the recommendations of an external review of the Global
HIV Prevention Coalition and the previous Road Map, conducted in 2020.
13
Table 2
summarizes the progress made in implementing the 2020 Road Map and the key gaps
remaining that require action.
910111213
The development of the new Road Map built on the consultative processes that shaped
the Global AIDS Strategy (2021–2026) and involved additional consultations with partners
in the Global HIV Prevention Coalition including national AIDS coordinating authorities
from all regions, United Nations teams at global, regional and country levels, funding
partners, civil society organizations and networks of key populations and adolescent girls
and young women.
9 Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020 Road Map. First progress report, March 2018. Geneva:
UNAIDS; 2018 (https://hivpreventioncoalition.unaids.org/wp-content/uploads/2018/06/JC2927_UNAIDS-WHA-Report.pdf).
10 Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020 Road Map. Second progress report, April–December 2018.
Geneva: UNAIDS; 2019 (https://hivpreventioncoalition.unaids.org/wp-content/uploads/2019/05/Second-Progress-Report_HIV-Prevention-
Roadmap_2019.pdf).
11 Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020 Road Map. Third progress report, October 2019. Geneva:
UNAIDS; 2019 (https://www.unaids.org/en/resources/documents/2019/PCB45_HIV_Prevention-2020-Road-Map).
12 Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020 Road Map. Fourth progress report, November 2020.
Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/documents/2020/fourth-annual-progress-report-of-the-global-hiv-prevention-
coalition).
13 de Zalduondo BO, Gelmon L, Jackson H. External review of the Global HIV Prevention Coalition. Geneva: UNAIDS; 2020
(https://www.unaids.org/sites/default/les/media_asset/PCB47_CPR2_External_Review_GPC.pdf).
6
TABLE 2.
Progress made and actions for addressing the remaining HIV prevention gaps
KEY BARRIERS
IDENTIFIED IN 2017 PROGRESS MADE ACTIONS TO BE TAKEN BY 2025
Limited political
leadership in HIV
prevention
HIV prevention rmly established on
the global agenda and in the Global
AIDS Strategy (2021–2026).
Active national HIV prevention
coalitions and working groups in
several focus countries.
Commitment of leaders at all levels
to increase investments in HIV
prevention, recognizing the increased
resource needs.
National leadership structures to
mobilize all relevant sectors to
take meaningful actions for HIV
prevention.
Policy and structural
obstacles to HIV
prevention services
Greater recognition of key
populations in national plans
everywhere.
Stronger commitment to address
multifaceted vulnerability of
adolescent girls and young women
and their male partners in sub-
Saharan Africa.
Advocate for and take practical
steps to address barriers to service
access and adopt all recommended
elements of HIV prevention and harm
reduction packages.
Accelerate policy reform and
decriminalization of key populations,
and reduce discrimination against key
and priority populations.
Strengthen collaboration with
other initiatives such as the Global
Partnership for Action to Eliminate
All Forms of HIV-Related Stigma and
Discrimination and the Education
Plus Initiative.
Limited HIV
prevention nancing
Large and stable PEPFAR investment
in HIV prevention.
Trend of declining HIV prevention
nancing through the Global Fund
halted and reversed.
Increasing number of countries
providing domestic nancing for HIV
prevention.
Make an evidence-based investment
case for HIV prevention (including
a focus on key populations, new
prevention technologies and
community-led responses), mobilize
sustainable nancing, and improve
allocative efciency to close the large
remaining nancing gap.
Manage nancing transitions to
enable full domestic funding of
HIV prevention in middle-income
countries.
Limited
implementation at
scale
Increased coverage of voluntary
medical male circumcision and pre-
exposure prophylaxis.
Increased coverage of specic
programmes for adolescent girls and
young women.
Increases in key population service
access in countries.
Scale up HIV prevention services for
all populations and locations with
high or growing HIV incidence.
Develop and implement systematic
and sustainable HIV prevention
programmes (not just projects).
Set up systems to manage and
coordinate decentralized services.
7
GETTING HIV PREVENTION
ON TRACK TO END AIDS
Every region offers inspiring examples of countries that have shown the commitment, mobilized the
resources and applied rights-based public health approaches to curb their HIV epidemics. Themost
successful countries have directed resources towards high-impact combination HIV prevention
programmes and they have supported and worked with community-led responses that reach
thepopulations and places most in need (see box).
HIV PREVENTION TARGETS CAN BE ACHIEVED IN
DIVERSE EPIDEMICS
Several countries have had striking success in reducing HIV incidence by scaling up
combination prevention programmes. Zimbabwe has reduced new HIV infections
by nearly 90% since the late 1990s, while Côte d’Ivoire’s early expansion of key
population programmes and an increase in antiretroviral coverage contributed to a
72% decline in new HIV infections in 2010–2020. In South Africa, new HIV infections
decreased by 45% in that same period as the country expanded HIV treatment and
voluntary medical male circumcision, while Kenya used the same approach, along
with high coverage of prevention services among key populations, to reduce HIV
incidence by 44%.
In other regions, several countries have achieved steep reductions in new HIV
infections by focusing their combination prevention programmes on the needs of key
populations. In Cambodia, Thailand and Viet Nam, new HIV infections declined
by more than 60% in 2010–2020, and they declined by about half in El Salvador,
Republic of Moldova and Sri Lanka. In Estonia, the expansion of comprehensive
harm reduction services was followed by a 61% countrywide reduction in HIV
infections and a 97% reduction in new diagnoses among people who inject drugs
between 2007 and 2016.
Sources: Evidence review: Implementation of the 2016–2021 UNAIDS Strategy: on the fast-
track to end AIDS. Geneva: UNAIDS; 2020 (https://www.unaids.org/sites/default/les/media_
asset/PCB47_CRP3_Evidence_Review_EN.pdf);
Confronting inequalities: Lessons for pandemic responses from 40 years of AIDS. Global AIDS
Update 2021. Geneva: UNAIDS; 2021 (https://www.unaids.org/sites/default/les/media_
asset/2021-global-aids-update_en.pdf).
8
However, the progress in reducing new infections has been too slow and it is occurring in too few
countries to reach the global targets. The number of new infections among adults decreased by
only 31% in 2010–2020, far short of the 75% target for 2020 which the UN General Assembly had
set in 2016. A much steeper decline is needed very quickly if the 2025 global target is to be reached
(Figure 3). Doing so demands that countries employ evidence-based prevention methods on a
sufcient scale, remove structural hindrances, such as punitive laws and policies, that impede their HIV
responses, and tackle the inequalities and the stigma and discrimination that fuel their epidemics.
FIGURE 3.
Estimated new HIV infections globally and by region, 2010–2020,
and projected new infections if the 2025 targets are met
Source: Prevailing against pandemics by putting people at the centre—World AIDS Day report. Geneva: UNAIDS; 2020
(https://www.unaids.org/en/resources/documents/2020/prevailing-against-pandemics).
9
In every region of the world, populations which face the highest risk of HIV are being
left behind when it comes to accessing and using HIV prevention services and tools.
Persistent inequalities, harassment and discrimination push them to the margins
and sabotage their health and well-being. Those experiences typify the lives of key
populations such as gay men and other men who have sex with men, people who
inject drugs, sex workers, transgender people, and people in prisons and other closed
settings. Key populations and their sexual partners accounted for an estimated 65% of
new HIV infections worldwide in 2020 and 93% of infections outside sub-Saharan Africa.
Systematic inequalities also blight the lives of women and girls, who account for half of all
new HIV infections globally. In high-incidence settings in sub-Saharan Africa, adolescent
girls and young women (aged 15–24 years) accounted for 25% of HIV infections in 2020,
even though they represented only 10% of the total population.
14
The COVID-19 pandemic and other international crises add further challenges. They have
widened inequalities and threaten to push the HIV response further off track. COVID-
19-related demands on health services, reallocations of health and other resources, and
disrupted HIV and other health programmes threaten to set back progress made against
the HIV pandemic. Social restrictions and shutdowns have thrust many millions of people
(especially women) deeper into poverty and have interrupted the education of hundreds
of millions more. COVID-19 has been characterized by worsening gender inequalities
and increased violence against women and girls and key populations. It has also seen
an erosion of human rights and a surge in punitive legal and policy measures in some
settings. The provision of HIV services to key and priority populations is also threatened
in conict situations and humanitarian crises.
15
The HIV Prevention 2025 Road Map lays out the actions that must be taken to overcome
these and other challenges. It recognizes that the HIV epidemic is constantly evolving and
that it differs across and within countries. National, regional and local epidemics often
have distinct characteristics that may shift over time and that make xed, one-size-ts-all
responses inappropriate and ineffective. Differentiated programmes and interventions
that correspond to their specic contexts are needed.
14 Confronting inequalities: Lessons for pandemic responses from 40 years of AIDS. Global AIDS Update 2021. Geneva: UNAIDS; 2021
(https://www.unaids.org/sites/default/les/media_asset/2021-global-aids-update_en.pdf).
15 Preventing HIV infections at the time of a new pandemic: a synthesis report on programme disruptions and adaptations during the
COVID-19 pandemic in 2020. Geneva: UNAIDS; 2021 (https://www.unaids.org/en/resources/documents/2021/20210701_HIVPrevention_new_
pandemic).
10
Crucially, the Road Map sharpens the focus on achieving the 95% coverage target for
all individuals who are at risk of HIV infection.
16
It emphasizes high-impact prevention
programmes for key and priority populations and the vital roles of community-led
activities to implement them on a scale that will decisively reduce new HIV infections. It
calls for discontinuing investments in interventions of limited effectiveness and efciency,
and for reallocating those resources. It underscores the need to end the inequalities that
fuel the HIV epidemic and hold back efforts to end it. And it highlights the importance of
sound management and accountability processes as part of a multisectoral response.
HIV thematic party for adolescents and young people organized by Teenergizer’s team in Kyiv,
Ukraine, in June 2019. Teenergizer provides peer psychological support to adolescents living with HIV,
HIV prevention, testing and counselling services and supports youth leadership in the region.
Credit: Teenergizer
16 Prevailing against pandemics by putting people at the centre: World AIDS Day report 2020. Geneva: UNAIDS; 2020 (https://www.unaids.
org/sites/default/les/media_asset/prevailing-against-pandemics_en.pdf).
11
TEN-POINT ACTION PLAN FOR
COUNTRY-LEVEL ACTIONS TO REACH
THE 2025 TARGETS AND GET ON TRACK
TO END AIDS BY 2030
The 2025 Road Map identies ten priority actions that countries must take to resolve the
remaining gaps and rebuild momentum to end AIDS as a public health threat by 2030.
1. CONDUCT AN EVIDENCE-DRIVEN ASSESSMENT OF HIV PREVENTION
PROGRAMME NEEDS AND BARRIERS
MILESTONES DUE BY
12-week Road Map
acceleration phase–dene
country-specic action
agendas for accelerating
HIV prevention up to 2025
February 2023
Identify key country-level
barriers and priorities
related to (1) leadership,
(2) nancing, (3) policy
and structural barriers, (4)
implementation at scale
April 2023
Using disaggregated data, conduct an up-to-date
analysis of epidemic patterns and trends at national
and subnational levels for all key populations and
priority populations (including new infections in
children using stack bar analysis).
Conduct a stock-taking exercise (with the participation
of relevant national stakeholders) to review national
progress in implementing prevention programmes at
scale.
Ensure that stock-taking identifies the policy, legal
and societal obstacles affecting service access and
use by key and priority populations, as well as critical
technical and capacity needs to address gaps.
Draw on available data in annual country HIV
prevention scorecards to identify priorities and gaps.
2. ADOPT APRECISION PREVENTION APPROACH FOCUSED ON KEY AND
PRIORITY POPULATIONS INCLUDING DIFFERENTIATED NATIONAL 2025
PREVENTION TARGETS
MILESTONES DUE BY
All countries translate global
HIV prevention targets
into granular national and
subnational HIV prevention
targets based on detailed
subnational and population-
specic data
February 2023
Update national HIV
Prevention Road Map
based on new global
and national targets and
country-specic barriers
April 2023
Organize inclusive national consultations for
agreement on programme priorities based on
evidence-driven assessments.
Identify the populations and locations with the
greatest HIV prevention needs, as well as those who
are not being reached with services.
Adopt or adjust interventions and approaches shown
to reduce new HIV infections, with an appropriate
balance between biomedical, behavioural and
structural approaches.
Focus resources and set coverage and uptake targets
that are high enough to achieve large impact.
12
3. DETERMINE COUNTRY INVESTMENT NEEDS FOR ADEQUATELY SCALED
HIV PREVENTION RESPONSES AND ENSURE SUSTAINABLE FINANCING
MILESTONES DUE BY
All countries dene HIV
prevention investment
needs for 2023–2026 and
identify viable nancing
sources
February 2023
All countries develop
and begin implementing
fundraising strategies
to address key gaps in
current response
May 2023
All countries accurately
report annual prevention
budget allocations and
spending
December 2023
Develop country-specific financing targets and
benchmarks for HIV prevention, in line with national
priorities and global recommendations.
Prioritize allocations to evidence-based interventions
and programmes for people at greatest risk,
respecting equity and efficiency, and ensure
proportionate allocations for all essential components
of a combination prevention response.
Promote complementarity of resources (not
competition) for a holistic HIV response and as part
of the overall resource planning, mobilization, and
allocation. Avoid pitting prevention against testing
and treatment, or biomedical interventions against
behavioural and structural ones.
Identify and resolve inefficiencies. Reallocate
investments from low-impact and low-efficiency
interventions to evidence-based alternatives that have
greater impact, equity and efficiency.
Promote public financing of community-led
prevention services through social contracting and
similar mechanisms.
Pursue diversified resource mobilization approaches
and partnerships (as appropriate to the country
context).
Identify opportunities for multisectoral investment in
combination prevention components––with multiple
sectors investing in mutually supportive interventions
(e.g. education, social protection, violence mitigation,
legal reform, access to justice, and reduction of stigma
and discrimination).
March in support of AIDS response in South Africa in 2016. Credit: UNAIDS
13
INVESTING ADEQUATELY IN HIV PREVENTION
More resources are needed to get the HIV pandemic response back on track to
end AIDS as a public health threat by 2030. UNAIDS has calculated that annual
HIV investments in low- and middle-income countries need to rise from the
US$ 21.5 billion in resources available in 2020 to US$ 29 billion in 2025. International
resources have at-lined in recent years and have been prioritized in low-income and
high-burden settings. The majority of the funding to reach the 2025 targets may be
expected from domestic resources; development partners must commit to sustainably
fund the remaining resource needs.
Signicantly larger investments are needed in three areas:
Primary HIV prevention. An almost two-fold increase in resources for evidence-based
prevention, from US$ 5.3 billion per year in 2019 to US$ 9.5 billion in 2025 (Figure 4).
HIV testing and treatment. Investments must increase by 18%, from US$ 8.4 billion
in 2019 to US$ 10.1 billion by 2025. Even though the number of people on HIV
treatment is expected to increase by 35%, efciency gains from price reductions in
commodities and cost savings in service delivery are estimated to keep the overall
costs down. Reaching the treatment targets will contribute to additional reductions in
new HIV infections and in treatment costs in the long term.
Societal enablers. Investments in societal enablers in low- and middle-income
countries need to increase from US$ 1.3 billion in 2019 to US$ 3.1 billion in 2025 (to
11% of total resource needs). These investments should be focused on removing
legal and policy barriers to HIV services, ending the criminalization of key populations,
providing legal literacy training and aid to people living with HIV and key populations
whose rights are violated, and contributing to efforts to achieve gender equality.
FIGURE 4.
Estimated global resource needs by populations and
primary prevention interventions, 2019 and 2025
0
2
4
6
8
10
2019 2025
2019 CONSTANT BILLION DOLLARS
Sex workers
Gay men and other men who have sex with men
Transgender people
People who inject drugs
Prisoners
Adolescent girls and young women
Adolescent boys and young men
Pre-exposure prophylaxis
Sexually transmitted infections Condoms Voluntary medical male circumcision
Prevention programmes for key populations and core services to achieve the targets,
low- and middle-income countries, 2019 and 2025 (2019 US$ billion).
Source: UNAIDS financial estimates and projections, 2021.
14
4. REINFORCE HIV PREVENTION LEADERSHIP ENTITIES FOR
MULTISECTORAL COLLABORATION, OVERSIGHT AND MANAGEMENT
OF PREVENTION RESPONSES
MILESTONES DUE BY
Nationally Developed
Milestones: three strategic
milestones are determined
February 2023
Report on achievement of
Nationally Dened Milestones
December 2023
Strengthen national and subnational entities
responsible for overseeing implementation of HIV
prevention programmes, including those outside the
public health sector.
Maximize synergies between different components of
combination prevention programmes.
Build unity of purpose between government,
communities, implementers, and other partners
around an evidence-based HIV prevention agenda,
with clearly defined roles and functions and in line
with their comparative advantages.
Include community-led organizations and other civil
society actors in mechanisms for coordination, decision-
making and oversight of prevention responses.
Provide the assigned national entity with adequate
resources to lead cross-sectoral collaboration, support
joint planning processes, and support the management
of programme implementation at all levels.
Assign sufficient authority to the national entity to hold
all actors accountable for progress towards national
targets and commitments (national AIDS commissions
typically perform this role).
5. STRENGTHEN AND EXPAND COMMUNITY-LED HIV PREVENTION
SERVICES AND SET UP SOCIAL CONTRACTING MECHANISMS
MILESTONES DUE BY
All countries have convened
government entities,
programme implementers
and communities of key and
priority populations to dene
the scaling-up of trusted
community access platforms
for HIV prevention, testing,
treatment and support
February 2023
Nationally Developed
Milestones: three strategic
milestones are determined
by local communities, and
achieved
December 2023
Promote community leadership and foster
community-led activities so that communities have
the knowledge, power and capacity to decide on
priorities in HIV prevention programmes and deliver
services.
Set national and subnational targets for increasing
the proportion of HIV prevention services delivered
by community-led organizations, in line with
commitments in the 2021 Political Declaration on HIV
and AIDS, and the Global AIDS Strategy (2021–2026).
Provide adequate funding to community-led and other
civil society organizations that are active in HIV prevention.
Establish legal frameworks, effective mechanisms
and transparent procedures for social contracting to
enable public financing of community-led and other
nongovernmental organizations to implement HIV-
related programmes, provide services and conduct
advocacy work.
Invest in strengthening technical and managerial
capacity of community-led organizations.
Facilitate augmenting international financing of
community-led services with domestic funding to
enhance programme ownership and sustainability.
15
THE IMPORTANCE OF COMMUNITY
LEADERSHIP IN HIV PREVENTION
Communities play vital roles in the HIV response by promoting accountability, driving
prevention activism, implementing activities and contributing innovations that are
crucial for sustainable progress.
17,18
Community-led service delivery platforms are often
more effective than formal health facility-based platforms for reaching marginalized
and under-served populations, especially in settings where stigma and discrimination
are rife.
19
Community-led organizations are well placed to identify gaps in services,
constraints that hold back service delivery and uptake, and opportunities to make
services more people-centred, convenient and effective.
Community-led service delivery extends beyond the health domain. This is seen in the
valuable contributions made to advocacy for legal and policy reforms, the monitoring
of human rights violations, and actions to support communities with violence
mitigation, legal literacy and livelihood assistance.
The 2021 Political Declaration on HIV and AIDS, and the Global AIDS Strategy (2021–
2026) call for increasing the proportion of HIV services delivered by communities,
including by ensuring that, by 2025, community-led organizations deliver, as
appropriate in the context of national programmes:
30% of testing and treatment services, with a focus on HIV testing, linkage to
treatment, adherence and retention support, and treatment literacy;
80% of HIV prevention services for populations at high risk of HIV infection, including
for women within those populations;
60% of programmes to support the achievement of societal enablers.
20, 21
Empowering young Brazilians to talk to their peers about HIV as part of the Viva Melhor Sabendo
Jovem (VMSJ) Salvador project led by UNICEF in 2019. The project goal is to raise awareness among
other young people about the importance of HIV testing and prevention. Credit: UNICEF
17 Communities at the centre: Global AIDS Update 2019. Geneva: UNAIDS; 2019 (https://www.unaids.org/sites/default/les/media_
asset/2019-global-AIDS-update_en.pdf).
18 Preventing HIV infections at the time of a new pandemic: a synthesis report on programme disruptions and adaptations during the
COVID-19 pandemic in 2020. Geneva: UNAIDS; 2021.
19 Communities at the centre: Global AIDS Update 2019. Geneva: UNAIDS; 2019 (https://www.unaids.org/sites/default/les/media_
asset/2019-global-AIDS-update_en.pdf).
20 Political Declaration on HIV and AIDS: ending inequalities and getting on track to end AIDS by 2030. New York: United Nations; 2021
(https://www.unaids.org/sites/default/les/media_asset/2021_political-declaration-on-hiv-and-aids_en.pdf).
21 Global AIDS Strategy 2021–2026: End inequalities, end AIDS. Geneva: UNAIDS; 2021 (https://www.unaids.org/sites/default/les/media_
asset/global-AIDS-strategy-2021-2026_en.pdf).
16
6. REMOVE SOCIAL AND LEGAL BARRIERS TO HIV
PREVENTION SERVICES FOR KEY AND PRIORITY
POPULATIONS
22 2021 Global AIDS Monitoring. Geneva: UNAIDS; 2021 (https://www.aidsdatahub.org/sites/default/les/resource/unaids-global-aids-
monitoring-2021.pdf).
23 See AIDSInfo website: https://onlinedb.unaids.org/ncpi/libraries/aspx/Home.aspx.
24 Global Partnership for Action to Eliminate All Forms of HIV-Related Stigma and Discrimination. Geneva: UNAIDS; 2018
(https://www.unaids.org/sites/default/les/media_asset/global-partnership-hiv-stigma-discrimination_en.pdf).
25 Every adolescent girl in Africa completing secondary school, safe, strong, empowered: Time for Education Plus. Geneva: UNAIDS; 2021
(https://www.unaids.org/sites/default/les/media_asset/JC3016_EducationPlusBrochure_En.pdf).
26 For example, the Global Fund’s Breaking Down Barriers Initiative and the Global Commission on HIV and the Law.
MILESTONES DUE BY
All countries have dened
and are implementing specic
actions to address policy and
structural barriers
February 2023
Nationally Developed
Milestones: local
communities decide on
and achieve three to ve
strategic milestones
December 2023
Support the creation of enabling legal and policy
environments (including by achieving the 10-10–10
targets, see box), and increased access to justice, gender
equality and freedom from stigma and discrimination, in
line with the Global AIDS Strategy (2021–2026).
Act to address key impediments blocking access to
and utilization of prevention services (e.g. HIV-
related stigma and discrimination; the criminalization
of drug use, sex work and same-sex sexual
relationships; gender inequalities and obstructive
age related consent policies and practices). Base the
actions on the findings of available assessments of
policy, legal and societal environments (e.g. the HIV
Stigma Index, legal environment assessments,
integrated biobehavioural surveys, Global AIDS
Monitoring and the National Commitments and
Policy Instrument databases
22, 23
,
gender assessment
tools and community-led research).
Engage national policy-makers and opinion leaders
to participate in cross-country briefings on reducing
policy barriers.
Strengthen collaboration between the Global HIV
Prevention Coalition and other global initiatives, such
as the Global Partnership for Action to Eliminate All
Forms of HIV-Related Stigma and Discrimination
24
,
the Education Plus Initiative
25
,
and others.
26
THE 10–10–10 TARGETS FOR REMOVING SOCIETAL AND
LEGAL BARRIERS TO HIV SERVICES
The 2025 targets can only be achieved in an environment where people living with HIV and
people at risk of HIV infection can use the services and adopt the behaviours that will protect
their health. Those conditions are lacking in many countries. As a result, HIV-related stigma and
discrimination, gender inequalities, the criminalization of drug use, sex work and same sex sexual
relationships, and age related consent requirements continue to undermine people’s health.
The 2021 UN Political Declaration on HIV and AIDS and the Global AIDS Strategy (2021–2026)
require that countries undertake reforms so that, by 2025:
Less than 10% of countries have legal and policy frameworks that lead to the denial or limitation of
access to HIV-related services;
Less than 10% of people living with HIV and key populations experience stigma and discrimination;
Less than 10% of women, girls, people living with HIV and key populations experience gender
inequality and violence.
Source: UNAIDS Global AIDS Strategy 2021–2026
17
7. PROMOTE THE INTEGRATION OF HIV PREVENTION INTO ESSENTIAL
RELATED SERVICES TO IMPROVE HIV OUTCOMES
MILESTONES DUE BY
Nationally Developed
Milestones: three strategic
milestones are determined
February 2023
Report on achievement of
Nationally Dened Milestones
December 2023
Capitalize on programme synergies to achieve the
best possible HIV outcomes.
Colocate, link or integrate services so they respond
to people’s needs, and are convenient and easy
to use. Of particular relevance is the integration of
HIV prevention services with services for sexual and
reproductive health, mental health, prevention and
care of sexual and gender-based violence, drug
dependence treatment, hepatitis C prevention
and care, tuberculosis control, prison health,
noncommunicable diseases, and legal and social
support services.
Support service integration for people who are
typically underserved by formal health systems,
including people who use drugs, people in prisons
and other closed settings, people on the move
(such as migrants), and people in emergency and
humanitarian contexts (such as refugees, displaced
populations and asylum seekers).
8. SET UP MECHANISMS FOR THE RAPID INTRODUCTION OF NEW HIV
PREVENTION TECHNOLOGIES AND PROGRAMME INNOVATIONS
MILESTONES DUE BY
All countries dene specic
actions for adapting new
HIV prevention technologies
(additional PrEP options,
virtual HIV intervention
approaches)
February 2023
Nationally Developed
Milestones: three strategic
milestones are determined
February 2023
Report on achievement of
Nationally Dened Milestones
December 2023
Promote the adoption of proven new HIV prevention
technologies as part of combination prevention
packages (e.g. antiretroviral drug releasing vaginal
rings or long-acting PrEP regimens).
Take forward a consultative process involving all
stakeholders (including community representatives,
training institutions and professional bodies) to
support the use of effective new technologies and
approaches.
Resolve policy, regulatory, logistical and guidance
challenges, and ensure the availability and
affordability of new technologies over time.
Support community delivery models to achieve
wide availability and use of HIV services and
technologies, including by strengthening virtual
interventions across prevention planning, community
engagement, outreach, demand generation, retention
and programme monitoring. Draw on innovations
pioneered or popularized by health service providers
and community-led organizations during the
COVID-19 pandemic (e.g. HIV self-testing, multimonth
dispensing of HIV treatment and prevention, digital
platforms and virtual meeting spaces).
18
9. ESTABLISH REAL-TIME PREVENTION PROGRAMME MONITORING
SYSTEMS WITH REGULAR REPORTING
MILESTONES DUE BY
Assess gaps in monitoring
and evaluation systems
and processes that lead to
incomplete HIV prevention
scorecards (coverage and
outcomes of programmes)
February 2023
Nationally Developed
Milestones: 3 strategic
milestones determined to
address gaps
February 2023
Complete reporting to Global
AIDS Monitoring allows for
full country scorecard report
March 2023
Strengthen subnational
monitoring and evaluation
systems, including non
health data, and put the
subnational scorecard
system into operation
December 2023
Make real-time tracking of progress central to
implementation of the ten-point Action Plan.
Regularly update global, national and subnational HIV
prevention scorecards.
Monitor the strengthening of national HIV prevention
coordination and management institutions.
Incorporate assessments of cost, cost-effectiveness
and value for money into traditional programme
performance measurements.
Include data from civil society and community-led
organizations when reporting on progress in relation
to the ten-point Action Plan.
Introduce regular high-level dialogues, joint reviews
and data reviews at subnational, national, regional
and global levels to inform prevention programme
improvements, course corrections and strategic
planning.
10. STRENGTHEN ACCOUNTABILITY OF ALL STAKEHOLDERS
FOR PROGRESS IN HIV PREVENTION
MILESTONES DUE BY
Institutionalize annual national
HIV prevention performance
review and accountability
process / meeting involving
government, communities
and other partners
April 2023
Establish quarterly
subnational performance
and accountability process
that involves government,
communities and other
partners
June 2023
Annual global and regional
meetings for accountability
Annually by
December
Strengthen data systems to underpin strong
accountability among all stakeholders.
Track national and subnational progress in
implementing the Road Map actions to identify
weaknesses and take corrective steps, and share
lessons learned and good practices.
Clearly identify, for each of the ten Action Plan points,
the key milestones that can realistically be achieved
by each country by the end of 2025.
Invest adequate resources in accountability processes
for optimal functionality and sustainability.
Given the pivotal role of community-led and other civil
society organizations in the HIV response, ensure that
accountability processes involve those organizations
in leading roles and reflect their assessments of
progress, and empower and fund them to expand
community-led monitoring capacity and systems.
Develop and monitor an accountability framework
that is grounded in government and community
leadership, transparency and sustainability (see pages
26-29 for more details).
19
STAYING FOCUSED ON THE
FIVE PREVENTION PILLARS
Alongside the HIV testing and antiretroviral treatment scale-up, countries have to
continue implementation of combination HIV prevention responses that encompass
biomedical, behavioural and structural interventions. The ve central pillars for national
HIV prevention responses described in the 2020 Road Map remain fundamentally
important to orient those efforts (Figure 5).
The ve-pillar approach has been rened in the 2025 Road Map to reect the emphasis
in the Global AIDS Strategy (2021–2026) and the demands of an evolving epidemic.
Highlighted now are people-centred approaches, addressing persistent inequalities in
access to and use of services and promoting integration and complementarity between
service delivery platforms.
Pillars 1–3 describe people-centred combination prevention packages for key populations
everywhere and for adolescents and young adults in geographical areas with high HIV
incidence. Programmes in these pillars include population specic behavioural and
structural actions that ensure access by communities to the full range of prevention
choices. Pillar 4 on condoms and Pillar 5 on antiretroviral-based prevention describe high-
impact prevention tools that are relevant to all populations. Pillar 5 emphasizes the vital
complementarity between HIV prevention and HIV treatment and care services.
Pillar 1, on key populations, applies globally, while Pillars 2 and 3 apply mostly in eastern
and southern Africa and in some locations in western and central Africa (settings with
high HIV incidence). Pillar 4 is also relevant globally, although outside sub-Saharan Africa
it mostly relates to prevention programmes for key populations (due to low HIV incidence
among other populations and generally widespread availability of condoms on the
commercial market). Pillar 5 is also relevant globally, with a focus on key populations and
HIV-discordant couples, though it is relevant for other populations as well as in settings in
eastern and southern Africa where HIV incidence is high.
The pillars rest on a foundation of other enhancements. These include sustained
investments, integrated service delivery platforms, the use of a multisectoral approach,
the creation of enabling environments, and actions to reduce inequalities. There is a
strong focus on addressing policy and structural barriers that hinder access to prevention
services, on ending stigma and discrimination, and on advancing gender equality.
20
FIGURE 5.
The five prevention pillars for 2025
KEY
POPULATIONS
ARV -BASED
PREVENTION
CONDOM
PROGRAMMING
ADOLESCENT
BOYS AND MEN
ADOLESCENT
GIRLS AND
YOUNG WOMEN
Fewer than 370 000
new HIV infections per year by 2025
95% of people at risk of HIV have equitable access to and use appropriate,
prioritized, person-centred and effective combination prevention options
ACCESS THROUGH
1 2 3 4
5
Combination
prevention and harm
reduction packages
for and with
· Sex workers
· Gay men and other
men who have sex
with men
· People who inject
drugs
· Transgender
people
· Prisoners
Combination
prevention packages
in settings with high
HIV incidence
(based on
differentiated,
layered packages)
Combination
prevention packages
in settings with high
HIV incidence
(including voluntary
medical male
circumcision and
promoting access to
testing and
treatment)
Promotion and
distribution of male
and female condoms
as well as lubricants
Pre-exposure
prophylaxis,
post-exposure
prophylaxis,
treatment as
prevention including
for elimination of
vertical transmission
Community-based and community-led outreach, health facilities including sexual and reproductive
health services, schools, private sector, virtual platforms and other innovations
Sexual and reproductive health and rights • Gender equality • Ending stigma and discrimination
Conducive policies and environment • Multisectoral, integrated & differentiated approach • Sustained investment in HIV prevention
FOUNDATIONS
SOCIETAL AND SERVICE ENABLERS AND ADDRESSING UNDERLYING INEQUALITIES
21
PILLAR 1.
Combination prevention for key populations
Much stronger and more extensive prevention programmes are needed for key populations,
which now account for almost two thirds of new HIV infections globally. Good examples of
programmes and required policy changes exist for all key populations, but coverage of HIV
services remains low and structural hindrances persist in a majority of countries.
Programmes for key populations must be evidence- and human rights-based, driven
by key population leadership and empowerment, and they must ensure stigma- and
discrimination-free access to services. That requires removing structural, policy and
legal barriers, including the criminalization of key populations, and ending stigma and
discrimination by health workers, law enforcement, justice sector, employers, education
providers and others. Trusted service platforms require robust outreach systems that
are peer-led and clinical services that are nonjudgmental, accessible and competent
in addressing key populations’ needs on the continuum of prevention, testing and
treatment services. Universal health coverage systems need to be structured in ways that
make these services accessible to all key populations.
Strengthened programmes should be implemented at scale and should be tailored to the HIV
and wider health needs of key populations. The programmes must encompass services for
preventing and treating HIV, tuberculosis, viral hepatitis and sexually transmitted infections
(including provision of condoms, lubricants and, where appropriate, PrEP and post-exposure
prophylaxis). Given the prominence of unsafe injecting drug use due to the limited availability
of needle and syringe programmes in the HIV epidemics in many countries, comprehensive
harm reduction services are vitally important, including in prisons and other closed settings.
The services therefore should include needle and syringe programmes, opioid substitution
therapy and naloxone, and should address the specic needs of women who use drugs.
All forms of compulsory drug and HIV testing and compulsory drug treatment should be
replaced with voluntary schemes.
Methadone distribution as opioid substitution therapy at Putao District
Hospital in Myanmar, 2019. Credit: UNAIDS
1
22
PILLAR 2.
Combination prevention for adolescent girls and young women in
high-prevalence locations
Despite a 39% decline in HIV incidence among young women aged 15–24 years in sub-
Saharan Africa between 2010 and 2020, adolescent girls and young adult women remain
greatly affected by HIV in parts of the region. Increased investment, including through the
United States President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund,
has enabled more than 40% of locations with high HIV incidence in 19 focus countries
in sub-Saharan Africa to implement dedicated combination prevention programmes for
young women. Those efforts must become more widespread to ensure access in 95% of
locations with high HIV incidence.
Combination prevention for adolescent girls and young women entails layered
programmes that address risk, vulnerability and service barriers and that provide a range
of reinforcing services. Recommended service packages include comprehensive sexuality
education (in and out of school), HIV and sexual and reproductive health services
(including male and female condoms and other contraceptive tools), antiretroviral-based
prevention and harm reduction for women who use drugs.
Gender inequalities and discrimination deny women and girls the ability to realize their
basic rights, including their right to education, good health, bodily autonomy and economic
well-being––all of which can also reduce their risk of HIV infection. Combination prevention
packages therefore comprise interventions to: change harmful gender norms; end gender-
based discrimination, inequalities and violence; improve social protection; and support
economic empowerment. These approaches feature in programmes such as Stepping
Stones, SASA!, South Africa’s national She Conquers programme and the PEPFAR-supported
Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) programmes.
There are opportunities to strengthen synergies between HIV and other endeavours, such
as those taken under the Education Plus Initiative and the Generation Equality Forum Action
Coalitions, as well as a range of sexual and reproductive health and rights initiatives.
27
PILLAR 3.
Combination prevention for men and adolescent boys in settings
with high HIV incidence
HIV prevention programmes for boys and men remain essential for their own health
and for the health of their female partners. Therefore, an expanded package on HIV
prevention for men and boys in settings with high HIV incidence is prioritized in the 2025
Road Map, while maintaining a strong focus on the provision of condoms, as well as on
voluntary medical male circumcision in 15 priority countries.
28
HIV prevention for men
and boys requires greater focus on increasing access to services within and outside clinic
settings including male-friendly services. This could entail community-based HIV testing,
self-testing, linkages to early antiretroviral treatment as required, condoms, pre-exposure
and post-exposure prophylaxis, comprehensive sexuality education and other sexual and
reproductive health services, and harm reduction.
27 United Nations Population Fund. Sexual and reproductive health and rights: an essential element of
universal health coverage. New York: UNFPA; 2019 (https://www.unfpa.org/sites/default/les/pub-pdf/
UF_SupplementAndUniversalAccess_30-online.pdf).
28 Voluntary medical male circumcision should continue to be promoted in 15 priority countries in
eastern and southern Africa: Botswana, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia,
Rwanda, South Africa, South Sudan, United Republic of Tanzania, Uganda, Zambia and Zimbabwe.
2
3
23
Voluntary medical male circumcision services need to reach greater numbers of adult
uncircumcised men who are at high risk of acquiring HIV infection. That calls for adaptations
to build demand and improve access, especially for men with lower incomes. It is essential
that these services be viewed as part of broader sexual and reproductive health services
for men and boys. They therefore should be offered as part of a package of services that
includes education on safe sex, on condom use and provision, and on healthy gender
norms, as well as information on HIV testing (and linkages to care and treatment, if
required), and prevention and management of sexually transmitted infections.
It is important to support these services with systematic efforts to promote gender
equitable norms and reduce gender-based violence. Several gender-transformative
programmes implemented in sub-Saharan Africa, such as One Man Can and others,
29
have shown potential for helping improve gender norms, address harmful aspects of
masculinities and reduce gender-based violence.
30
PILLAR 4.
Promotion of condoms and lubricants
Condoms remain the most widely used HIV prevention method and they are a low cost
option for the large numbers of people who are at moderately high risk of acquiring
HIV. Increased condom use is estimated to have averted more than 100 million new
HIV infections globally since 1990.
31
It also carries other sexual and reproductive health
benets, including the prevention of other sexually transmitted infections and unintended
pregnancies. However, gaps and inequities in condom access and use persist, and they
are widening in several countries in the context of reduced investment.
Strengthened national condom programmes are required.
This entails enhanced demand
creation (especially for new generations of potential users), procurement and supply of
male and female condoms as well as lubricants through free distribution, social marketing
and private sector sales to ensure full-scale access. Countries should act urgently to revive
condom programme stewardship, evidence-based design and total market approaches in
which the public, private and social marketing sectors complement one another.
Condom demand generation needs to reach a new generation of users. Credit: UNFPA
29 Engaging men and boys in gender equality and health: a global toolkit for action. New York: UNFPA;
2010 (https://www.unfpa.org/sites/default/les/pub-pdf/Engaging Men and Boys in Gender Equality.pdf).
30 Global sexual and reproductive health package for men and adolescent boys. New York: UNFPA;
2017. (https://www.unfpa.org/sites/default/les/pub-pdf/IPPF_UNFPA_GlobalSRHPackageMenAndBoys_
Nov2017.pdf).
31 Stover J, Teng Y. The impact of condom use on the HIV epidemic [version 1]. Gates Open Res. 2021;5:91.
4
24
PILLAR 5.
Wider access to antiretroviral based prevention, including PrEP
Pre-exposure prophylaxis is highly effective in preventing HIV infection. Despite progress
made in providing PrEP in a few Coalition focus countries, access in low- and middle-
income countries remains very low (less than 10% of the 2025 target). It is particularly
important to ensure access to key populations and other populations in settings with high
HIV incidence, as specied in Global AIDS Strategy (2021–2026) targets.
Such a scale-up requires increased investment and actions that address barriers to consistent
use. It calls for linking the roll-out of PrEP with related services (for example, HIV testing and
sexual and reproductive health) and with supportive social networks. Also needed are rapid
response mechanisms to introduce new prevention technologies and approaches as they
become available. The latter include the Dapivirine vaginal ring, which expands the choices
for HIV prevention available to women and adolescent girls at substantial risk of HIV infection,
and long-acting injectable antiretroviral formulations for PrEP.
Post-exposure prophylaxis has been under-utilized in HIV prevention response. It has
been a critical component of the clinical management of rape survivors
32
and in reducing
occupational risk, but remains largely unavailable outside clinical settings. There is
urgent need to address demand and supply-side barriers to the use of post-exposure
prophylaxis and increase access outside the health sector for key and priority populations.
Gaps in HIV testing and treatment, including among key populations and men, need to be
addressed urgently to realize the full benets of HIV testing and treatment. Necessary actions
include capitalizing more effectively on HIV testing as an entry for prevention and on HIV
prevention as an entry point for testing and treatment. Knowledge of HIV prevention benets
of treatment (undetectable = untransmittable, or U=U) also needs to increase.
Primary prevention, HIV treatment and programmes for elimination of vertical transmission
need to work hand-in-hand. New infections in children are also driven by newly acquired
maternal HIV infections during pregnancy and the breastfeeding period. This requires
increased focused on primary prevention for women and their partners through platforms for
the prevention of vertical transmission of HIV. HIV prevention for women and their partners
should be included in national guidelines for preventing vertical transmission and proven HIV
prevention choices, including PrEP, should be promoted for pregnant and lactating women
and their partners in areas of high HIV incidence.
32 Clinical management of rape and intimate partner violence survivors: developing protocols for use in
humanitarian settings. Geneva: WHO; 2022. https://www.who.int/publications/i/item/9789240001411
5
25
AN ACCOUNTABILITY FRAMEWORK
FOR HIV PREVENTION
Accountability is a priority in the 2025 Prevention Road Map as outlined earlier in Road
Map Action 10. Political leaders, HIV authorities, funding partners, private sector and civil
society partners have to be held accountable for promoting and managing multisectoral
prevention responses, and for mobilizing and allocating adequate nancing. They are
also responsible for implementing prevention programmes that match the scale and
characteristics of HIV epidemics in countries, and for establishing enabling environments
for those programmes.
A sound accountability framework (Table 3) achieves clarity and transparency about the
respective commitments and responsibilities. It is backed by adequate resources and
support for action, and it draws on regular monitoring and reliable reporting on progress.
Country teams using the Coalition scorecard for reviewing prevention results, GPC High-Level
Meeting, 2019, Kenya, Nairobi. Credit: UNAIDS
26
TABLE 3.
Accountability framework at all levels for HIV prevention
ACCOUNTABILITY FOR
ENSURING ACCOUNTABILITY AT THE COUNTRY-LEVEL
LED BY NATIONAL AIDS COORDINATING BODIES AND
SUPPORTED BY IN-COUNTRY COALITION MEMBERS
CROSS-CUTTING
MECHANISMS
Strong political
leadership in HIV
prevention
Semi-annual senior political leadership briengs.
Semi-annual reviews of political action agenda.
Annual high-level
global and regional HIV
Prevention Coalition
meetings.
National Coalition
multistakeholder
consultations before and
after annual global and
regional meetings.
Global tracking of
commitments followed
by problem-solving
dialogues.
Addressing legal and
policy barriers
Annual briengs with senior legislators and/or policy-makers.
Semi-annual dialogues on actions to address legal and
policy barriers (in collaboration with the Global Partnership
for Action to Eliminate All Forms of HIV-related Stigma and
Discrimination and building on the Global Commission on
HIV and the Law).
Adequate HIV
prevention nancing
Annual HIV prevention nancing dialogues with senior
leadership in health and nance ministries.
Annual prevention nance and investment tracking at global
and country levels.
Implementation
at scale
Annual performance reviews based on national and
subnational scorecards.
Quarterly programmatic progress-tracking and problem-
solving dialogues.
Ideally, accountability processes go beyond the necessary monitoring and evaluation
of performance (see box). In addition to being transparent regarding data and other
evidence, they should involve inclusive dialogue, set pragmatic deliverables and focus
on actions. Crucially, these processes need to involve all stakeholders in HIV prevention,
particularly the communities of people most affected by the HIV epidemic.
27
CORE CHARACTERISTICS OF WELL-FUNCTIONING
ACCOUNTABILITY PROCESSES
Accountability processes should be:
Participatory, inclusive, government-led and community-led. All
stakeholders in HIV prevention should participate in the design and
implementation of accountability processes. Affected communities have
key roles in these processes.
Transparent. The processes should be developed and conducted in a
transparent manner providing access to data, programme reviews, reports
and scorecards to the public and communities.
Contextualized. The processes should be adapted to their contexts. They
should reect the political context and the level of civic participation in
governance and decision-making.
Distinct. Monitoring and evaluation are crucial for accountability processes
(e.g. providing evidence to assess the performance of HIV prevention
activities). Accountability also involves assessing aspects of the prevention
response that go beyond indicators and targets; it includes aspects such
as transparency of decision-making, dialogue among stakeholders and the
upholding of human rights.
Several practical steps can be taken to strengthen the accountability processes related to
the HIV Prevention 2025 Road Map:
Host initial multistakeholder dialogues at national level shortly after the launch of the
2025 Road Map. These meetings will customize milestones and set annual progress
markers for each of the ten Action Plan points in the Road Map. The progress markers
can be selected by drawing on existing in-country work and can be supported
through existing facilities such as the UNAIDS Technical Support Mechanism. Ideally, a
minimum of three progress markers should be identified for each of the ten Action Plan
points. Where possible, markers can be aligned to indicators in the UNAIDS National
Commitments and Policy Instrument.
Make national dialogues inclusive (e.g. national AIDS councils, ministries of health
and other frontline ministries, donors, HIV service implementers, community-led
organizations and other civil society organizations, and the private sector) and uphold
the Greater Involvement of People living with or affected by HIV principle.
Incorporate the milestones and annual progress markers into a national accountability
plan, to be published on the Global HIV Prevention Coalition website. The
multistakeholder dialogues can be repeated annually to evaluate progress towards the
milestones.
Prepare a joint accountability report incorporating government and community
perspectives and data. The report complements the national prevention scorecards and
encompasses a broader scope of accountability.
28
Actively use the HIV Prevention Scorecard, with scores based on a combination of
coverage, output and outcome indicators for key programme components and societal
enablers in the Global AIDS Monitoring system. The Prevention Scorecard would
continue to guide the regular review of performance at all implementation levels and
highlight gaps in data that need to be addressed.
Collaborate with learning networks and create a knowledge-sharing platform on
accountability where countries can share their experiences. The Global HIV Prevention
Coalition Secretariat can convene discussions of significant problems and challenges.
Convene an initial global meeting of Global HIV Prevention Coalition members to review
national accountability plans and decide which progress markers for which the Coalition
Secretariat and other members will be accountable. Using country-level national
accountability plans as a starting point, Global Coalition members can determine the
specific actions and targets for which they are responsible.
Annually review progress in the Global HIV Prevention Working Group and the National
AIDS Council managers’ community of practice before presenting results at annual high-
level Coalition meetings.
The international community must lead a global push towards investment in HIV prevention.
Executive Directors of UNAIDS and UNFPA, Co-Conveners of the Global Prevention Coalition
during the 45th PCB of UNAIDS. Credit: UNAIDS
29
ANNEXES
ANNEX 1.
Commitments towards reducing new HIV infections
to fewer than 370000 per year by 2025
Governments will:
Lead the implementation of the ten-point Action Plan.
Set ambitious national and subnational HIV prevention programme, financing and
impact targets for 2025, in accordance with the 2021 Political Declaration and the Global
AIDS Strategy (2021–2026).
Develop national action plans that are in line with the scale-up targets. The plans should
be based on population size estimates and should define priority locations, populations
and service packages, and should emphasize delivery platforms for differentiated
services.
Adjust national result frameworks to ensure that 95% of key and priority groups in
settings with high HIV prevalence are accessing high-impact prevention services.
Take practical steps to achieve adequate and sustainable investments in HIV primary
prevention as part of a fully funded national HIV response.
Strengthen the national entity leading HIV prevention and empower it to hold actors
accountable, strengthen national and local accountability frameworks, and increase
national and local HIV prevention management capacity.
Build the capacity of the national entity leading HIV prevention to advance the
systematic integration of gender-transformative approaches in national HIV responses.
Provide the necessary funding and support to ensure the meaningful engagement
of community-led and other civil society organizations—including organizations
and networks of key populations and young people—in all aspects of the design,
implementation, and monitoring and evaluation of HIV policies and programmes.
Develop or revise social contracting mechanisms to facilitate government funding
for civil society implementers, and increase investments towards fulfilling the global
commitments for community-led service delivery.
Accelerate the necessary legal reforms and policy changes to remove legal, social,
economic and gender-related barriers that hold back HIV prevention.
Adopt proven new technologies and innovative strategies for HIV prevention.
Community-led and other civil society organizations will:
Sensitize decision-makers at all levels about the continued importance of primary
prevention, alongside the 95–95–95 testing and treatment agenda, and advocate for
evidence-informed policies and adequate investments.
Participate in the design and implementation of prevention programmes, as well as in
monitoring and accountability structures.
Advocate for funding, capacity building and support to expand community service
delivery platforms for key and priority populations.
30
Strengthen community systems, including community-led monitoring and surveillance,
to improve the quality of prevention services and of data, progress tracking and
reporting.
Hold governments and other actors accountable for progress towards prevention
targets through constructive advocacy, and further develop community accountability
structures for feedback, communication and problem solving between community
entities and government systems.
Advocate for legal and policy reforms, including the removal of punitive laws, the
lowering of obstructive age of consent requirements, and the abandonment of HIV-
related travel restrictions.
Develop and implement interventions to reduce HIV-related stigma and discrimination
across health, community, justice, workplace, education and humanitarian settings.
Funding and other development partners will:
Intensify their support for HIV prevention, considering the need to scale up both
treatment and prevention, including by financing implementation of the HIV Prevention
2025 Road Map.
Place greater emphasis on actions for achieving the HIV prevention targets, as well as
share lessons and promote best practices in planning, implementing and managing
prevention interventions.
Where needed, provide new or additional resources to neglected prevention
components such as condom programming and key population programmes, and
support community-led implementation and advocacy.
Support and facilitate price and access negotiations for making new prevention
technologies, including pharmaceutical products available at affordable prices in low-
and middle-income countries.
Increase and sustain adequate funding for HIV prevention across the five pillars in
countries that need donor support, and sustain funding in other countries to allow them
sufficient time to transition to domestic financing of prevention programmes.
Establish and/or support fit for purpose mechanisms for technical assistance for HIV
prevention, develop and disseminate implementation tools, and collect best practice
examples with designated leads for each pillar’s key functions.
Invest in scaling up gender-transformative interventions to change harmful gender
norms and end gender-based violence and harmful practices.
Provide support for creating and operating harmonized accountability mechanisms
(e.g. scorecards or dashboards).
The private sector will:
Expand corporate responsibility schemes to ensure comprehensive primary prevention
services for employees, their families and communities, and act to reduce stigma and
discrimination.
Support innovations in HIV prevention commodities, interventions and service delivery
approaches, and invest in health-related communication technologies and systems.
Share lessons for strengthening results based planning and service delivery systems,
such as logistics, supply chain management systems and the use of new media
technologies, as well as provide technical and other necessary support in those areas.
31
ANNEX 2.
Detailed HIV prevention targets in the
Global AIDS Strategy 2021–2026
The Global AIDS Strategy 2021–2026 requires the achievement of ambitious targets in all
populations and settings. To develop the targets for 2025, UNAIDS worked with partners
to review available evidence, including modelling, to determine the specic actions
needed to make the 2030 goal possible. As in prior target-setting exercises, this process
used an investment framework to identify the level and allocation of resources required
for achievement of the targets. A technical consultation on prevention targets was held
involving experts and stakeholders to review evidence and determine what is currently
working and needs to be continued, what is not working and needs to be changed, and
which key gaps in the response need to be addressed.
Detailed prevention targets were set for key populations (Table 4) and young people
and adults (Table 5). Both sets of targets are differentiated by the level of risk and are
based on the principle that higher coverage and more comprehensive services should be
provided where risk is higher.
Prevention targets for key populations were dened as follows:
Specific targets were set for all five key populations for all programme areas.
Within key populations, PrEP targets are further disaggregated by three risk categories.
Risk categories for PrEP targets are based on the following criteria (see Table 6 for details):
For sex workers and prisoners, risk categories are based on HIV prevalence in the
overall population as a proxy for the risk in the two populations.
For gay men and other men who have sex with men and transgender people, risk
categories are based on the estimated level of HIV incidence.
For people who inject drugs, risk categories for PrEP are based on the coverage of
harm reduction services.
Prevention targets for young people and adults were dened along the following lines:
Targets are disaggregated by age and sex.
Risk categories were defined based on the level of HIV incidence in specific
geographical areas and individual risk behaviours (see Table 7 for details).
For some programme areas, risk categories are defined based on the level of HIV
incidence by geography alone. This includes programmes that reduce susceptibility and
vulnerability over longer periods of time including voluntary medical male circumcision
and economic empowerment of women. It also includes post-exposure prophylaxis.
For other programme areas, risk categories are defined based on a combination of
behaviours and HIV incidence in the geographical area. This includes targets for services that
respond more directly to individual risk exposures such as condoms, PrEP and STI screening.
In addition to programmatic targets, the Global AIDS Strategy calls for ensuring that
80% of service delivery for HIV prevention programmes for key populations and women
be delivered by community, key population and women-led organizations. This target
specically refers to those programme components designed to reach key populations,
young people and women.
32
TABLE 4.
Prevention targets for key populations
KEY POPULATIONS
SEX
WORKERS
GAY MEN
AND OTHER
MEN WHO
HAVE SEX
WITH MEN
PEOPLE
WHO INJECT
DRUGS
TRANS-
GENDER
PEOPLE
PRISONERS
AND OTHERS
IN CLOSED
SETTINGS
Condom/lubricant use at
last sex by those not taking
PrEP with a nonregular
partner whose HIV viral
load status is not known to
be undetectable (includes
those who are known to be
HIV negative)
95% 95% 95%
Condom/lubricant use at
last sex with a client or
nonregular partner
90% 90%
PrEP use (by risk category)
Very high
High
Moderate and low
80%
15%
0%
50%
15%
0%
15%
5%
0%
50%
15%
0%
15%
5%
0%
Sterile needles and syringes 90% 90%
Opioid substitution therapy
among people who are
opioid dependent
50%
STI screening and treatment 80% 80% 80%
Regular access to
appropriate health system
or community-led services
90% 90% 90% 90% 100%
Access to post-exposure
prophylaxis as part of a
package of risk assessment
and support
90% 90% 90% 90% 90%
33
TABLE 5.
Targets for young people and adults by level of risk
YOUNG PEOPLE AND ADULTS 15–49
RISK BY PRIORITIZATION STRATUM
VERY HIGH
MODERATE
LOW
ALL AGES AND
GENDERS
Condoms/lubricant use at last
sex by those not taking PrEP with
a nonregular partner whose HIV
viral load status is not known to be
undetectable (includes those who are
known to be HIV negative)
95% 70% 50%
PrEP use (by risk category) 50% 5% 0%
STI screening and treatment 80% 10% 10%
ADOLESCENTS
AND YOUNG
PEOPLE
Comprehensive sexuality education in
schools, in line with UN international
technical guidance
90% 90% 90%
STRATA BASED ON GEOGRAPHY ALONE
VERY
HIGH
(>3%)
HIGH
(1–3%)
MODERATE
(0.3–1%)
LOW (<0.3%)
ALL AGES AND
GENDERS
Access to post-exposure prophylaxis
(nonoccupational exposure) as part
of package of risk assessment and
support
90% 50% 5% 0%
Access to post-exposure prophylaxis
(nosocomial) as part of package of risk
assessment and support
90% 80% 70% 50%
ADOLESCENT
GIRLS AND
YOUNG WOMEN
Economic empowerment 20% 20% 0% 0%
ADOLESCENT
BOYS AND MEN
Voluntary medical male circumcision 90% in 15 priority countries
PEOPLE WITHIN
SERODISCORDANT
PARTNERSHIPS
Condoms/lubricant use at last sex
by those not taking PrEP with a
nonregular partner whose HIV viral
load status is not known
95%
PrEP until positive partner has
suppressed viral load
30%
Post-exposure prophylaxis 100% after high-risk exposure
34
TABLE 6.
Thresholds for the prioritization of HIV prevention methods for key populations
CRITERION VERY HIGH HIGH MODERATE AND LOW
SEX WORKERS
National adult
(15–49 years)
HIV prevalence
>3% >0.3% <0.3%
PRISONERS
National adult
(15–49 years)
HIV prevalence
>10% >1% <1%
GAY MEN AND
OTHER MEN
WHO HAVE SEX
WITH MEN
UNAIDS analysis
by country/
region
Proportion of
populations
estimated to
have incidence:
>3%
Proportion of populations
estimated to have incidence:
0.3–3%
Proportion of populations
estimated to have incidence:
<0.3%
TRANSGENDER
PEOPLE
Mirrors gay men
and other men
who have sex
with men in the
absence of data
Proportion of
populations
estimated to
have incidence:
>3%
Proportion of populations
estimated to have incidence:
0.3–3%
Proportion of populations
estimated to have incidence:
<0.3%
PEOPLE WHO
INJECT DRUGS
UNAIDS analysis
by country/
region
Small needle–
syringe
programme
and low opioid
substitution
therapy
coverage
Limited needle–syringe
programme; limited opioid
substitution therapy
Wide needle–syringe
programme coverage
with adequate needles
and syringes per person
who injects drugs; opioid
substitution therapy
available
35
TABLE 7.
Thresholds for the prioritization of HIV prevention methods for young people and adults
CRITERION HIGH AND VERY HIGH MODERATE LOW
Adolescent
girls and young
women
Combination of national
or subnational incidence in
women 15–24 years AND
reported behaviour from
DHS or other ≥2 partners;
or reported STIs in previous
12 months
1–3%
incidence
AND
high-risk
reported
behaviour
>3%
incidence
0.3–<1%
incidence
and high-risk
reported
behaviour
OR
1–3%
incidence
and low-risk
reported
behaviour
<0.3%
incidence
OR
0.3–<1%
incidence
and low-risk
reported
behaviour
Adolescent
boys and
young men
Combination of national
or subnational incidence
in men 15–24 years AND
reported behaviour from
DHS or other ≥2 partners;
or reported STIs in previous
12 months
1–3%
incidence
AND
high-risk
reported
behaviour
>3%
incidence
0.3–<1%
incidence
and high-risk
reported
behaviour
OR
1–3%
incidence
and low-risk
reported
behaviour
<0.3%
incidence
OR
0.3–<1%
incidence
and low-risk
reported
behaviour
Adults (aged
25 and older)
Combination of national
or subnational incidence
in adults 25–49 years AND
reported behaviour from
DHS or other ≥2 partners;
or reported STI in previous
12 months
1–3%
incidence
AND
high-risk
reported
behaviour
>3%
incidence
0.3–<1%
incidence
and high-risk
reported
behaviour
OR
1–3%
incidence
and low-risk
reported
behaviour
<0.3%
incidence
OR
0.3–<1%
incidence
and low-risk
reported
behaviour
Serodiscordant
partnerships
Estimated number of HIV
negative regular partners
of someone newly starting
on treatment
Risk stratication depends on choices in the partnership: choice of timing
and regimen of antiretroviral therapy for the HIV positive partner; choice of
behavioural patterns (condoms, frequency of sex); choice of PrEP
36
ANNEX 3:
Members of the Global HIV Prevention Coalition
Co-conveners
Winnie Byanyima, Executive Director, Joint United
Nations Programme on HIV/AIDS
Natalia Kanem, Executive Director, United Nations
Population Fund
Focus countries
Angola
Botswana
Brazil
Cameroon
China
Côte d’Ivoire
Democratic Republic of the Congo
Eswatini
Ethiopia
Ghana
India
Indonesia
Islamic Republic of Iran
Kenya
Lesotho
Malawi
Mexico
Mozambique
Myanmar
Namibia
Nigeria
Pakistan
South Africa
Uganda
Ukraine
United Republic of Tanzania
Zambia
Zimbabwe
Donor countries
France
Germany
Netherlands
Norway
Sweden
United Kingdom
United States of America
International and regional organizations
African Union
Bill & Melinda Gates Foundation
Children’s Investment Fund Foundation
Joint United Nations Programme on HIV/AIDS Secretariat
and Cosponsors
Reproductive Health Supplies Coalition
Southern African Development Community
The Global Fund
United States President’s Emergency Plan for AIDS Relief
Civil society organizations and networks
African Youth and Adolescent Network on Population
and Development (AFRIYAN)
AVAC
FP2020
Frontline AIDS
Global Action for Trans Equality (GATE)
Global Action for Gay Men’s Health and Rights (MPACT)
Global Network of People living with HIV (GNP+)
Global Network of Sex Work Projects (NSWP)
International Association of Providers of AIDS Care
(IAPAC)
International Community of Women Living with HIV
(ICW)
International Network of People Who Use Drugs
(INPUD)
International Network of Religious Leaders Living
with or personally affected by HIV and AIDS (INERELA+)
International Planned Parenthood Federation (IPPF)
Others
Centre for the AIDS Programme of Research in South
Africa (CAPRISA)
International AIDS Society (IAS)
Reference Group on HIV and Human Rights
37
ANNEX 4.
Successful HIV prevention supports achievement of the Sustainable
Development Goals
Preventing HIV is vital for ending the AIDS epidemic as a public health threat and for
achieving the Sustainable Development Goals.
TABLE 8.
The HIV response in the context of the Sustainable Development Goals
Healthy lives
and well-being
for all, at all
ages
Universal
health
coverage,
including HIV
prevention
services
Universal
access to
sexual and
reproductive
health
Universal
access to drug
dependence
treatment and
harm reduction
Inclusive and
equitable
quality
education and
promotion of
lifelong learning
opportunities
for all
High-quality
education,
including on
comprehensive
sexual and
reproductive
health
Empowerment
of young
people and
life skills for
responsible
and informed
sexual and
reproductive
health decisions
Gender
equality and
empowerment
of all women
and girls
Sexual and
reproductive
health and
rights
Elimination of
violence and
harmful gender
norms and
practices
Reduced
inequality
within and
among
countries
Protection
against
discrimination
alongside legal
services
Rights literacy,
access to
justice and
international
protection
Empowerment
of people to
claim their
rights and
enhance access
to HIV services
Global
partnership
for sustainable
development
Policy
coherence
International
support
for
implementing
effective
capacity
building
Reduced
violence
including
against key
populations
and people
living with HIV
Promotion of
the rule of law
Effective,
accountable
and transparent
institutions
Inclusive,
participatory
and
representative
decision-
making
38
ANNEX 5.
Summary of achievements and lessons from implementation of
the2020 HIV Prevention Road Map
The ten-point Action Plan described in the 2020 Prevention Road Map laid out the
steps which each country needed to take to accelerate progress in HIV prevention.
Itcalled for a streamlined but robust strategic planning and programme management
effort. It also offered a framework for supporting monitoring and accountability by
using country scorecards and the Coalition’s progress reports.
Guided by the Action Plan and Road Map, countries have made considerable progress,
as shown in Table 9. Key elements of those achievements included strong political
commitment, increased investments in HIV prevention, a clear vision and practical
strategy that encompasses well-dened core packages, decentralized service delivery,
community-led action and peer led outreach, and continuous monitoring and quality
assurance. Partnerships with civil society and community engagement have markedly
strengthened national and subnational responses.
According to the nal survey of the 2020 Road Map actions, however, none of the focus
countries had completed all ten steps. Côte d’Ivoire, India, Kenya and South Africa had
completed or initiated action on all but two of the steps, while Cameroon, Democratic
Republic of the Congo and Lesotho had done so for all but three of the steps. Even
though the overall targets were not met, there had been heartening progress against
most of the ten Action Plan points.
Almost all the focus countries had carried out prevention needs assessments, set
prevention targets and drafted or updated their prevention strategies. There was
increased action towards legal and policy reforms, and a large majority of focus
countries had done nancial gap analyses and had strengthened their programme
monitoring and performance review processes. But key population size estimates had
been completed in only four of the 28 reporting countries (although they were under
way in all but two countries) and policy reforms to facilitate more effective prevention
among key populations were progressing too slowly. Dened service packages for
key populations were not yet in place in most of the focus countries. Progress on
capacity building and technical support plans was also slow and social contracting was
uncommon and becoming more difcult.
Underlying factors included insufcient political commitment and investment,
inadequate attention to data systems and management, and insufcient action
to address the social and contextual complexities experienced by vulnerable and
marginalized groups––particularly key populations and adolescent girls and women.
These populations continue to face numerous barriers in accessing HIV and sexual
and reproductive health services, including legal and policy hindrances, stigma and
discrimination, gender inequalities, and gender-based violence. Laws that criminalize
key populations remain in place in most countries, although they have been relaxed
or reformed in some. With such minimal progress, such laws and prohibitions remain
a major barrier to HIV prevention programming in many countries. In most of the
focus countries, prevention programmes are still weakest in delivering and monitoring
interventions with and for key populations.
The 2020 HIV Prevention
Road Map helped to anchor
HIV prevention within
national HIV responses.
Coalition members have
all reported using the
Road Map to chart the
way forward at a national
level. Other countries have
also used it to guide their
national responses. The
Road Map has provided
many leaders and decision-
makers with a basis for
implementing the Global
HIV Prevention Coalition
vision by developing
frameworks and crafting
strategies to scale up
country-led HIV prevention
programmes.
39
HIV PREVENTION ROADMAP
10-POINT PLAN ACTIONS
Timeline
Lesotho
United Republic of Tanzania
Democratic Republic of the Congo
Cameroon
Eswatini
South Africa
Côte d’Ivoire
Kenya
Namibia
Zimbabwe
Nigeria
Uganda
India
Malawi
Pakistan
Islamic Republic of Iran
China
Ethiopia
Zambia
Angola
Indonesia
Mozambique
Myanmar
Mexico
Brazil
Ukraine
Ghana
Botswana
1. HIV prevention needs assessment
2017
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
1. HIV prevention needs assessment
2018
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
1. HIV prevention needs assessment
2019
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
1. HIV prevention needs assessment
2020
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
TABLE 9.
Summary of implementation of 2020 Road Map actions
Done In progress Not done
Not applicable Progress not submitted
*Countries are scored as “done” if they report having conducted population size estimates and
dened service packages for all 5 key population groups: (i) gay men and other men who have sex
with men, (ii) sex workers, (iii) people who inject drugs, (iv) transgender persons and (v) people in
prison. In progress” reects actions on 3-4 groups and “not done” reects actions on 0-2 groups.
40
HIV PREVENTION ROADMAP
10-POINT PLAN ACTIONS
Timeline
Lesotho
United Republic of Tanzania
Democratic Republic of the Congo
Cameroon
Eswatini
South Africa
Côte d’Ivoire
Kenya
Namibia
Zimbabwe
Nigeria
Uganda
India
Malawi
Pakistan
Islamic Republic of Iran
China
Ethiopia
Zambia
Angola
Indonesia
Mozambique
Myanmar
Mexico
Brazil
Ukraine
Ghana
Botswana
1. HIV prevention needs assessment
2017
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
1. HIV prevention needs assessment
2018
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
1. HIV prevention needs assessment
2019
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
1. HIV prevention needs assessment
2020
2. HIV prevention targets
3. HIV prevention strategy
4. Legal and policy reform actions
5a. Key population size estimates*
5b. Dened key population service packages*
5c. Adolescent girls and young women size estimates
5d. Dened adolescent girls and young women service package
6. Capacity building and technical assistance plan
7. Social contracting mechanisms
8. Financial gap analysis
9. Strengthened programme monitoring
10. Programme performance review
ANNEX 6
The Global HIV Prevention Coalition in the context of other initiatives
The Global HIV Prevention Coalition operates alongside other key initiatives (Table 10).
TABLE 10.
The Global HIV Prevention Coalition and its complementarity to other global initiatives
GLOBAL HIV
PREVENTION
COALITION
95–95–95 AND
ASSOCIATED
WORKING
GROUPS
10–10–10
TARGETS AND
ASSOCIATED
INITIATIVES
GLOBAL
ALLIANCE TO
END AIDS IN
CHILDREN
EDUCATION
PLUS INITIATIVE
FOCUS
HIV prevention
among young
people and
adults
HIV testing and
treatment, and
differentiated
service delivery
Includes the
The Global
Partnership
to Eliminate
all forms of
HIV-related
Stigma and
Discrimination
Elimination
of vertical
transmission of
HIV, treatment
of children and
prevention
services for
adolescent
girls and young
women
Access to
education for
girls and young
women, gender
equality
CONTRIBUTION
TO THE
PREVENTION
AGENDA
Lead and track
the global HIV
prevention
response
Increased viral
suppression
directly reduces
new HIV
infections
HIV testing is an
entry point for
prevention
HIV treatment
is an entry point
for prevention
for partners
Reduce legal and
policy barriers
to accessing
HIV prevention
services affecting
key populations,
young people
and women
in settings
with high HIV
incidence
Reduce new
HIV infections in
children
Reduction of
new infections
in adolescent
girls and young
women and
pregnant and
breastfeeding
women
Increase
access through
secondary
education plus
comprehensive
sexuality
education; access
to sexual and
reproductive
health services;
end violence
against
women and
girls; promote
women’s
economic
empowerment;
strengthen
leadership of
women living
with and affected
by HIV
AREAS OF
COLLABORATION
Key population community access platforms for prevention,
testing, treatment and rights
Access platforms for women, particularly adolescent girls and young women as well as women and their
partners, and actions to address harmful gender norms and gender inequalities that affect HIV prevention
National strategic planning and coordination to minimize duplication and maximize complementarity
41
ANNEX 7.
Reference list and further reading
1. Peter Sands interview (https://hivpreventioncoalition.unaids.org/wp-content/
uploads/2021/06/Mr-Peter-Sands.pdf, accessed 1 October 2021).
2. Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020
Road Map. First progress report, March 2018. Geneva: UNAIDS; 2018 (https://
hivpreventioncoalition.unaids.org/wp-content/uploads/2018/06/JC2927_UNAIDS-
WHA-Report.pdf, accessed 18 August 2021).
3. Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020 Road
Map. Second progress report, April–December 2018. Geneva: UNAIDS; 2019 (https://
hivpreventioncoalition.unaids.org/wp-content/uploads/2019/05/Second-Progress-
Report_HIV-Prevention-Roadmap_2019.pdf, accessed 18 August 2021).
4. Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020
Road Map. Third progress report, October 2019. Geneva: UNAIDS; 2019 (https://
hivpreventioncoalition.unaids.org/wp-content/uploads/2020/02/20200205_JC2980_
GPC-Report-2019_En.pdf, accessed 18 August 2021).
5. Global HIV Prevention Coalition. Implementation of the HIV Prevention 2020 Road
Map. Fourth progress report, November 2020. Geneva: UNAIDS; 2020 (https://
hivpreventioncoalition.unaids.org/wp-content/uploads/2020/11/fourth-annual-
progress-report.pdf, accessed 18 August 2021).
6. de Zalduondo BO, Gelmon L, Jackson H. External review of the Global HIV Prevention
Coalition. Geneva: UNAIDS; 2020 (https://www.unaids.org/sites/default/les/media_
asset/PCB47_CPR2_External_Review_GPC.pdf, accessed 18 August 2021)
7. Decisions of the Virtual 47th Session of the UNAIDS Programme Coordinating Board.
Geneva: 15-18 December 2020 (https://www.unaids.org/sites/default/les/media_
asset/Decisions_(PCB47)_Final_EN_rev1.pdf, accessed 9 September 2021).
8. Political Declaration on HIV and AIDS: ending inequalities and getting on track to end
AIDS by 2030. New York, United Nations; 2021 (https://www.unaids.org/sites/default/
les/media_asset/2021_political-declaration-on-hiv-and-aids_en.pdf), accessed
18August 2021.
9. Stover J, Teng Y. The impact of condom use on the HIV epidemic [version 1]. Gates
Open Res. 2021;5:91. doi: 10.12688/gatesopenres.13278.1
10. Global Partnership for Action to Eliminate all forms of HIV-related Stigma and
Discrimination. Geneva: UNAIDS; 2018 (https://www.unaids.org/sites/default/
les/media_asset/global-partnership-hiv-stigma-discrimination_en.pdf, accessed
24November 2021).
11. HIV Prevention 2020 Road Map. Accelerating HIV prevention to reduce new infections
by 75%. Geneva: UNAIDS; 2018 (https://hivpreventioncoalition.unaids.org/wp-
content/uploads/2018/03/JC2909_INCLUSION-GAP_013_En-2.pdf, accessed
18August 2021).
12. Communities at the centre: Global AIDS Update 2019. Geneva: UNAIDS; 2019
(https://www.unaids.org/sites/default/les/media_asset/2019-global-AIDS-update_
en.pdf, accessed 26 November 2021)
42
13. Prevailing against pandemics by putting people at the centre: World AIDS Day report
2020. Geneva: UNAIDS; 2020 (https://www.unaids.org/sites/default/les/media_
asset/prevailing-against-pandemics_en.pdf, accessed 18 August 2021)
14. Key population trusted access platforms: considerations in planning and budgeting
for a key population platform to deliver scaled quality HIV prevention and
treatment services and for addressing critical enablers. Geneva: UNAIDS; 2020
(https://hivpreventioncoalition.unaids.org/wp-content/uploads/2020/04/Budget-
Considerations-for-KP-Trusted-Access-Platforms-April-2-2020-Final-V-1.1a-no-TCs-1.
pdf, accessed 9 September 2021).
15. Evidence review: implementation of the 2016-2021 UNAIDS Strategy: on the fast-
track to end AIDS. Geneva: UNAIDS; 2020 (https://www.unaids.org/sites/default/les/
media_asset/PCB47_CRP3_Evidence_Review_EN.pdf, accessed 18 August 2021).
16. Seizing the moment. Tackling entrenched inequalities to end epidemics. Global
AIDS Update 2020. Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/
documents/2020/global-aids-report, accessed 9 September 2021).
17. Confronting inequalities: lessons for pandemic responses from 40 years of AIDS.
Global AIDS Update 2021. Geneva: UNAIDS; 2021 (https://www.unaids.org/sites/
default/les/media_asset/2021-global-aids-update_en.pdf, accessed 9 September
2021).
18. Global AIDS Strategy 2021–2026: end inequalities, end AIDS. Geneva: UNAIDS;
2021. (https://www.unaids.org/sites/default/les/media_asset/global-AIDS-
strategy-2021-2026_en.pdf, accessed 18 August 2021).
19. Preventing HIV infections at the time of a new pandemic: a synthesis report on
programme disruptions and adaptations during the COVID-19 pandemic in 2020.
Geneva: 2021 (https://www.unaids.org/en/resources/documents/2021/20210701_
HIVPrevention_new_pandemic, accessed 18 August 2021).
20. Every adolescent girl in Africa completing secondary school, safe, strong,
empowered: Time for Education Plus. Geneva: UNAIDS; 2021 (https://www.unaids.
org/sites/default/les/media_asset/JC3016_EducationPlusBrochure_En.pdf, accessed
24November 2021).
21. Sexual and reproductive health and rights: an essential element of universal health
coverage. New York: United Nations Population Fund; 2019 (https://www.unfpa.
org/sites/default/les/pub-pdf/UF_SupplementAndUniversalAccess_30-online.pdf,
accessed 7 September 2021)
22. Engaging men and boys in gender equality and health: a global toolkit for action.
New York: United Nations Population Fund; 2010 (https://www.unfpa.org/sites/
default/les/pub-pdf/Engaging Men and Boys in Gender Equality.pdf, accessed
9September 2021).
23. Global sexual and reproductive health package for men and adolescent boys. New
York: UNAIDS; 2017 (https://www.unfpa.org/sites/default/les/pub-pdf/IPPF_UNFPA_
GlobalSRHPackageMenAndBoys_Nov2017.pdf, accessed 9 September 2021).
43
© Joint United Nations Programme on HIV/AIDS (UNAIDS), 2022
Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO
licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo/).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the
work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that UNAIDS endorses
any specic organization, products or services. The use of the UNAIDS logo is not permitted. If you adapt the work, then
you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work,
you should add the following disclaimer along with the suggested citation: “This translation was not created by UNAIDS.
UNAIDS is not responsible for the content or accuracy of this translation. The original English edition shall be the binding
and authentic edition”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of
the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules).
Suggested citation. HIV PREVENTION 2025 – ROAD MAP: Getting on track to end AIDS as a public health threat by 2030.
Geneva: Joint United Nations Programme on HIV/AIDS; 2022. Licence: CC BY-NC-SA 3.0 IGO.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, gures
or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from
the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests
solely with the user.
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion
whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which
there may not yet be full agreement.
The mention of specic companies or of certain manufacturers’ products does not imply that they are endorsed or
recommended by UNAIDS in preference to others of a similar nature that are not mentioned. Errors and omissions excepted,
the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by UNAIDS to verify the information contained in this publication. However, the
published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the
interpretation and use of the material lies with the reader. In no event shall UNAIDS be liable for damages arising from its use.
UNAIDS/JC3053E
UNAIDS
Joint United Nations
Programme on HIV/AIDS
20 Avenue Appia
1211 Geneva 27
Switzerland
+41 22 791 3666
unaids.org